These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38032457)

  • 21. Hyperparathyroidism and increased fractional excretion of phosphate predict allograft loss in long-term kidney transplant recipients.
    Prakobsuk S; Sirilak S; Vipattawat K; Taweesedt PT; Sumethkul V; Kantachuvesiri S; Disthabanchong S
    Clin Exp Nephrol; 2017 Oct; 21(5):926-931. PubMed ID: 27981393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet.
    Leca N; Laftavi M; Gundroo A; Kohli R; Min I; Karam J; Sridhar N; Blessios G; Venuto R; Pankewycz O
    Am J Transplant; 2006 Oct; 6(10):2391-5. PubMed ID: 16869807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D, parathyroid hormone, and bone mineral density status in kidney transplant recipients.
    Savaj S; Ghods FJ
    Iran J Kidney Dis; 2012 Jul; 6(4):295-9. PubMed ID: 22797100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of mineral metabolism markers on renal transplant outcomes.
    Marcén R; Jimenez S; Fernández A; Galeano C; Villafruela JJ; Burgos FJ; Quereda C
    Transplant Proc; 2012 Nov; 44(9):2567-9. PubMed ID: 23146456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal.
    Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Campistol JM
    Transplant Proc; 2012 Oct; 44(8):2376-8. PubMed ID: 23026597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism.
    Serra AL; Wuhrmann C; Wüthrich RP
    Am J Kidney Dis; 2008 Dec; 52(6):1151-7. PubMed ID: 18950915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.
    Cruzado JM; Moreno P; Torregrosa JV; Taco O; Mast R; Gómez-Vaquero C; Polo C; Revuelta I; Francos J; Torras J; García-Barrasa A; Bestard O; Grinyó JM
    J Am Soc Nephrol; 2016 Aug; 27(8):2487-94. PubMed ID: 26647424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Parathyroidectomy Timing in Kidney Transplant Recipients on Graft Function.
    Oruc A; Ersoy A; Yildiz A; Oz Gul O; Ersoy C
    Exp Clin Transplant; 2021 Apr; 19(4):316-323. PubMed ID: 30346261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cinacalcet in the treatment of persistent hyperparathyroidism after kidney transplantation.
    Pinho LR; Ribeiro Santos MJ; Pestana Vasconcelos M
    Clin Nephrol; 2011 Mar; 75(3):263-8. PubMed ID: 21329638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cinacalcet in renal transplant patients with hyperparathyroidism.
    Courbebaisse M; Diet C; Timsit MO; Mamzer MF; Thervet E; Noel LH; Legendre C; Friedlander G; Martinez F; Prié D
    Am J Nephrol; 2012; 35(4):341-8. PubMed ID: 22473131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary hyperparathyroidism after kidney transplantation: a cross-sectional study.
    Marcén R; Ponte B; Rodríguez-Mendiola N; Fernández Rodriguez A; Galeano C; Villafruela JJ; Teruel JL; Burgos FJ; Ortuño J
    Transplant Proc; 2009; 41(6):2391-3. PubMed ID: 19715929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet.
    Apostolou T; Damianou L; Kotsiev V; Drakopoulos S; Hadjiconstantinou V
    Clin Nephrol; 2006 May; 65(5):374-7. PubMed ID: 16724661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total parathyroidectomy without autotransplantation after renal transplantation for tertiary hyperparathyroidism: long-term follow-up.
    Sadideen HM; Taylor JD; Goldsmith DJ
    Int Urol Nephrol; 2012 Feb; 44(1):275-81. PubMed ID: 21997202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
    Bhan I; Shah A; Holmes J; Isakova T; Gutierrez O; Burnett SM; Jüppner H; Wolf M
    Kidney Int; 2006 Oct; 70(8):1486-94. PubMed ID: 16941023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia.
    Okada M; Tominaga Y; Sato T; Tomosugi T; Futamura K; Hiramitsu T; Ichimori T; Goto N; Narumi S; Kobayashi T; Uchida K; Watarai Y
    BMC Nephrol; 2022 Jun; 23(1):212. PubMed ID: 35710357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological analysis of persistent hypercalcemia and hyperparathyroidism after kidney transplantation in long-term dialysis patients.
    Nakamura M; Tanaka K; Marui Y; Tomikawa S
    Ther Apher Dial; 2013 Oct; 17(5):551-6. PubMed ID: 24107283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effects of preemptive kidney transplantation on calcium and phosphorus disorders in early post-transplant recipients.
    Tsujita M; Inaguma D; Goto N; Yamamoto T; Hiramitsu T; Katayama A; Takeda A; Kobayashi T; Morozumi K; Uchida K; Narumi S; Watarai Y; Tominaga Y
    Clin Exp Nephrol; 2015 Apr; 19(2):319-24. PubMed ID: 24706030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism.
    Serra AL; Schwarz AA; Wick FH; Marti HP; Wüthrich RP
    Nephrol Dial Transplant; 2005 Jul; 20(7):1315-9. PubMed ID: 15941845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New-Onset Hypercalcemia After Renal Transplant: An Infectious Etiology Beyond Persistent Hyperparathyroidism.
    Koymen G; Celtik A; Cinkooglu A; Toz S; Asci G; Arda B; Toz H; Erdinc M
    Exp Clin Transplant; 2022 Jul; 20(7):691-694. PubMed ID: 34142941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients.
    Caravaca F; Fernández MA; Ruiz-Calero R; Cubero J; Aparicio A; Jimenez F; García MC
    Nephrol Dial Transplant; 1998 Oct; 13(10):2605-11. PubMed ID: 9794568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.